ABBOTT DIABETES CARE H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ABBOTT DIABETES CARE is $133,900, based on 127 certified filings from FY 2020 to FY 2026. This is 12% higher than the national H-1B median salary of $120,000. Compensation at ABBOTT DIABETES CARE reflects their market positioning, with entry-level roles starting around $115,300 and senior positions reaching $185,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ABBOTT DIABETES CARE range from $95,500 at the 10th percentile to $185,000 at the 90th percentile, showing a $89,500 spread across experience levels and roles. The 25th percentile is $115,300 and the 75th percentile is $160,000.

Yes, ABBOTT DIABETES CARE actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 129 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 127 certified applications and a 0% denial rate, ABBOTT DIABETES CARE maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ABBOTT DIABETES CARE filed 4 H-1B applications, with 4 certified and 0 denied. Over 7 years of data, ABBOTT DIABETES CARE has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ABBOTT DIABETES CARE's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 129 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ABBOTT DIABETES CARE as a potential H-1B sponsor.

This is an excellent approval rate, indicating ABBOTT DIABETES CARE has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ABBOTT DIABETES CARE sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 127 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ABBOTT DIABETES CARE most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ABBOTT DIABETES CARE:

The most frequently sponsored role is Senior Software Engineer with 18 filings at a median salary of $170,000. This is followed by Software Engineer (11 filings) and Senior QA Engineer.

ABBOTT DIABETES CARE's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ABBOTT DIABETES CARE sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ABBOTT DIABETES CARE H-1B locations:

The largest H-1B hub for ABBOTT DIABETES CARE is Alameda, CA with 108 filings at a median salary of $133,900. The highest-paying location is San Jose, CA at $200,000 median. Salaries range from $110,000 to $200,000 across office locations.

ABBOTT DIABETES CARE's median H-1B salary has increased by +73% from FY 2020 ($110,000) to FY 2026 ($190,000). Tracking salary trends over time reveals how ABBOTT DIABETES CARE adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ABBOTT DIABETES CARE.

Year-by-year breakdown:

• FY 2022: $130,000 (29 certified)
• FY 2023: $130,000 (9 certified)
• FY 2024: $149,000 (35 certified)
• FY 2025: $133,432 (35 certified)
• FY 2026: $190,000 (4 certified)

This 73% growth reflects strong compensation adjustments at ABBOTT DIABETES CARE, keeping pace with market demands for H-1B talent.

ABBOTT DIABETES CARE primarily files H-1B applications at Wage Level II, accounting for 50% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ABBOTT DIABETES CARE's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 89% of positions at Level II or higher, ABBOTT DIABETES CARE typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ABBOTT DIABETES CARE's median H-1B salary of $133,900 is 12% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ABBOTT DIABETES CARE's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ABBOTT DIABETES CARE's offerings with similar companies in your field for a more accurate assessment.

ABBOTT DIABETES CARE offers above-average H-1B compensation. Combined with their 127 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ABBOTT DIABETES CARE files 11% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 127 certified filings, ABBOTT DIABETES CARE invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.